Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review

PJ van Rosendael, V Delgado, JJ Bax - European heart journal, 2018 - academic.oup.com
Aims The incidence of new-onset conduction abnormalities requiring permanent pacemaker
implantation (PPI) after transcatheter aortic valve implantation (TAVI) with new-generation …

Impact of complications during transfemoral transcatheter aortic valve replacement: how can they be avoided and managed?

R Scarsini, GL De Maria, J Joseph, L Fan… - Journal of the …, 2019 - Am Heart Assoc
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic
stenosis and is the treatment of choice for patients at prohibitive and high surgical risk …

Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial

NM Van Mieghem, GM Deeb, L Søndergaard… - JAMA …, 2022 - jamanetwork.com
Importance In patients with severe aortic valve stenosis at intermediate surgical risk,
transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve …

5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients

TG Gleason, MJ Reardon, JJ Popma, GM Deeb… - Journal of the American …, 2018 - jacc.org
Abstract Background: The CoreValve US Pivotal High Risk Trial was the first randomized
trial to show superior 1-year mortality of transcatheter aortic valve replacement (TAVR) …

Bicuspid aortic valve morphology and outcomes after transcatheter aortic valve replacement

SH Yoon, WK Kim, A Dhoble, S Milhorini Pio… - Journal of the American …, 2020 - jacc.org
Background Bicuspid aortic stenosis accounts for almost 50% of patients undergoing
surgical aortic valve replacement in the younger patients. Expanding the indication of …

Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial

H Thiele, T Kurz, HJ Feistritzer, G Stachel… - European Heart …, 2020 - academic.oup.com
Aims Transcatheter aortic valve implantation (TAVI) has emerged as established treatment
option in patients with symptomatic aortic stenosis. Technical developments in valve design …

The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction

JM Khan, AB Greenbaum, VC Babaliaros… - JACC: Cardiovascular …, 2019 - jacc.org
Abstract Objectives: The BASILICA (Bioprosthetic or native Aortic Scallop Intentional
Laceration to prevent Iatrogenic Coronary Artery obstruction during TAVR) investigational …

Expanding the indications for transcatheter aortic valve implantation

Z Rahhab, N El Faquir, D Tchetche… - Nature Reviews …, 2020 - nature.com
Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of
symptomatic severe aortic valve stenosis. Current guidelines recommend TAVI in patients at …

Five-year clinical and echocardiographic outcomes from the NOTION randomized clinical trial in patients at lower surgical risk

HGH Thyregod, N Ihlemann, TH Jørgensen, H Nissen… - Circulation, 2019 - Am Heart Assoc
Background: The NOTION trial (Nordic Aortic Valve Intervention) was designed to compare
transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement …

Balloon versus self-expandable valve for the treatment of bicuspid aortic valve stenosis: insights from the BEAT international collaborative registrys

A Mangieri, D Tchetchè, WK Kim… - Circulation …, 2020 - Am Heart Assoc
Background: Large data comparing the performance of new-generation self-expandable
versus balloon-expandable transcatheter heart valves in bicuspid aortic stenosis are …